Literature DB >> 15172026

"Best practice" in inflammatory bowel disease: an international survey and audit.

Ingrid Van Der Eijk1, Frank W. Verheggen, Maurice G. Russel, Martin Buckley, Kostas Katsanos, Pia Munkholm, Ingemar Engdahl, Patrizia Politi, Selwyn Odes, Jan Fossen, Reinhold W. Stockbrügger.   

Abstract

Background: An observational study was conducted at eight university and four district hospitals in eight countries collaborating in clinical and epidemiological research in inflammatory bowel disease (IBD) to compare European health care facilities and to define current "best practice" with regard to IBD.
Methods: The approach used in this multi-national survey was unique. Existing quality norms, developed for total hospital care by a specialized organization, were restricted to IBD-specific care and adapted to the frame of reference of the study group. In each center, these norms were surveyed by means of questionnaires and professional audits in all participating centers. The collected data were reported to the center, compared to data from other hospitals, and used to benchmark. Group consensus was reached with regard to defining current "best practice".
Results: The observations in each center involved patient-oriented processes, technical and patient safety, and quality of the medical standard. Several findings could be directly implemented to improve IBD care in another hospital (benchmarks). These included a confidential relationship between health care worker(s) and patients, and availability of patient data. Conclusions: The observed benchmarks, in combination with other subjectively chosen "positive" procedures, have been defined as current "best practice in IBD", representing practical guidelines towards better quality of care in IBD.

Entities:  

Year:  2004        PMID: 15172026     DOI: 10.1016/j.ejim.2004.01.016

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  6 in total

1.  Findings from the European collaborative inflammatory bowel disease database.

Authors:  Pia Munkholm
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-10

2.  Design and development of EMR supporting medical process management.

Authors:  Jing-Song Li; Xiao-Guang Zhang; Jian Chu; Muneou Suzuki; Kenji Araki
Journal:  J Med Syst       Date:  2012-06       Impact factor: 4.460

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

4.  Performance assessment of EMR systems based on post-relational database.

Authors:  Hai-Yan Yu; Jing-Song Li; Xiao-Guang Zhang; Yu Tian; Muneou Suzuki; Kenji Araki
Journal:  J Med Syst       Date:  2011-04-19       Impact factor: 4.460

Review 5.  Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870).

Authors:  Lotte Dinesen; Simon Travis
Journal:  Int J Nanomedicine       Date:  2007

Review 6.  Optimising the Inflammatory Bowel Disease Unit to Improve Quality of Care: Expert Recommendations.

Authors:  Edouard Louis; Iris Dotan; Subrata Ghosh; Liat Mlynarsky; Catherine Reenaers; Stefan Schreiber
Journal:  J Crohns Colitis       Date:  2015-05-18       Impact factor: 9.071

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.